B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+0.15%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.03B
AUM Growth
+$3.03B
(+1.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
102
New
13
Increased
18
Reduced
21
Closed
19
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$77.6M |
| 2 |
Harrow
HROW
|
$30.7M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$28.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$25.6M |
| 5 |
Terns Pharmaceuticals
TERN
|
$23.6M |
Top Sells
| 1 |
Natera
NTRA
|
$35.5M |
| 2 |
Travere Therapeutics
TVTX
|
$30.6M |
| 3 |
QuidelOrtho
QDEL
|
$25.7M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$23.8M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 54.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
HilleVax
HLVX
$105M
| $26.8M | 0.88% | 1,620,216 | – | – |
|
27
Aclaris Therapeutics
ACRS
$209M
| $26.4M | 0.87% | 3,269,094 +875,109 | +37% | +$7.08M |
|
|
28
Terns Pharmaceuticals
TERN
$609M
| $23.6M | 0.78% | +1,997,055 | New | +$23.6M |
|
29
AnaptysBio
ANAB
$569M
| $21.2M | 0.7% | 973,073 +246,951 | +34% | +$5.37M |
|
30
Immunocore
IMCR
$1.62B
| $21.1M | 0.69% | +426,110 | New | +$21.1M |
|
|
DBVT
31
DBV Technologies
DBVT
$264M
| $20.5M | 0.67% | 12,107,785 | – | – |
|
32
Alector
ALEC
$238M
| $19.8M | 0.65% | 3,206,315 +2,481,291 | +342% | +$15.4M |
|
33
Syndax Pharmaceuticals
SNDX
$1.41B
| $19.4M | 0.64% | 920,049 -322,753 | -26% | -$6.82M |
|
34
Globus Medical
GMED
$8.27B
| $19M | 0.63% | 335,200 -8,426 | -2% | -$477K |
|
|
FNA
35
DELISTED
Paragon 28, Inc.
FNA
| $18.8M | 0.62% | +1,098,722 | New | +$18.8M |
|
36
Steris
STE
$24.1B
| $18.3M | 0.6% | 95,694 | – | – |
|
|
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $16.8M | 0.55% | 452,000 +38,400 | +9% | +$1.43M |
|
38
BioCryst Pharmaceuticals
BCRX
$1.74B
| $16.2M | 0.54% | +1,945,134 | New | +$16.2M |
|
39
Dyne Therapeutics
DYN
$1.92B
| $15.9M | 0.52% | 1,377,872 +624,727 | +83% | +$7.2M |
|
40
Vir Biotechnology
VIR
$686M
| $14.1M | 0.46% | +604,036 | New | +$14.1M |
|
41
Mersana Therapeutics
MRSN
$36.5M
| $13.8M | 0.45% | 3,355,805 +1,493,105 | +80% | +$6.14M |
|
42
Pulmonx
LUNG
$69.7M
| $13M | 0.43% | 1,163,294 -458,200 | -28% | -$5.12M |
|
43
Pacific Biosciences
PACB
$393M
| $12.7M | 0.42% | +1,097,300 | New | +$12.7M |
|
44
Compass Therapeutics
CMPX
$483M
| $10.6M | 0.35% | 3,247,847 +1,433,581 | +79% | +$4.69M |
|
45
Arcellx
ACLX
$3.85B
| $10.3M | 0.34% | +333,800 | New | +$10.3M |
|
46
argenx
ARGX
$43.6B
| $9.17M | 0.3% | 24,600 -24,600 | -50% | -$9.17M |
|
|
AXNX
47
DELISTED
Axonics, Inc. Common Stock
AXNX
| $9.1M | 0.3% | +166,704 | New | +$9.1M |
|
48
Mineralys Therapeutics
MLYS
$1.03B
| $8.62M | 0.28% | +550,300 | New | +$8.62M |
|
49
Transmedics
TMDX
$3.92B
| $7.46M | 0.25% | 98,459 -204,726 | -68% | -$15.5M |
|
50
Nuvation Bio
NUVB
$1.02B
| $6.84M | 0.23% | 4,122,900 | – | – |
|